Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Expression pattern of ISL-1, TTF-1 and PAX5 in olfactory neuroblastoma.

Czapiewski P, Gorczyński A, Haybaeck J, Okoń K, Reszeć J, Skrzypczak W, Dzierżanowski J, Kunc M, Karczewska J, Biernat W.

Pol J Pathol. 2016 Jun;67(2):130-5.

2.

Expression of SOX11, PAX5, TTF-1 and ISL-1 in medulloblastoma.

Czapiewski P, Gorczynski A, Radecka K, Wiewiora C, Haybaeck J, Adam P, Fend F, Zakrzewska M, Zakrzewski K, Liberski PP, Biernat W.

Pathol Res Pract. 2016 Nov;212(11):965-971. doi: 10.1016/j.prp.2016.08.006. Epub 2016 Aug 11.

PMID:
27623204
3.

Calretinin staining facilitates differentiation of olfactory neuroblastoma from other small round blue cell tumors in the sinonasal tract.

Wooff JC, Weinreb I, Perez-Ordonez B, Magee JF, Bullock MJ.

Am J Surg Pathol. 2011 Dec;35(12):1786-93. doi: 10.1097/PAS.0b013e3182363b78.

PMID:
22020045
4.

Expression of the human Achaete-scute 1 gene in olfactory neuroblastoma (esthesioneuroblastoma).

Carney ME, O'Reilly RC, Sholevar B, Buiakova OI, Lowry LD, Keane WM, Margolis FL, Rothstein JL.

J Neurooncol. 1995 Oct;26(1):35-43.

PMID:
8583243
5.

[Clinicopathologic study of sinonasal teratocarcinosarcoma and its contrast with olfactory neuroblastoma].

Li X, Liu HG, Xie XJ, Han YD, Li M.

Zhonghua Bing Li Xue Za Zhi. 2008 Jul;37(7):458-64. Chinese.

PMID:
19035117
6.

The cytologic features of sinonasal undifferentiated carcinoma and olfactory neuroblastoma.

Bellizzi AM, Bourne TD, Mills SE, Stelow EB.

Am J Clin Pathol. 2008 Mar;129(3):367-76. doi: 10.1309/C00WN1HHJ9AMBJVT.

PMID:
18285258
7.

The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: Refinements in diagnostic criteria and impact of multimodal treatments on survival.

Turri-Zanoni M, Maragliano R, Battaglia P, Giovannardi M, Antognoni P, Lombardi D, Morassi ML, Pasquini E, Tarchini P, Asioli S, Foschini MP, Sessa F, Nicolai P, Castelnuovo P, La Rosa S.

Oral Oncol. 2017 Nov;74:21-29. doi: 10.1016/j.oraloncology.2017.09.010.

PMID:
29103747
8.

TTF-1 and PAX5 Are Frequently Expressed in Combined Merkel Cell Carcinoma.

Czapiewski P, Majewska H, Kutzner H, Kazakov D, Renkielska A, Biernat W.

Am J Dermatopathol. 2016 Jul;38(7):513-6. doi: 10.1097/DAD.0000000000000464.

PMID:
27322785
9.

Olfactory neuroblastoma (esthesioneuroblastoma) and esthesioneuroepithelioma: histologic and immunohistochemical study.

Taraszewska A, Czorniuk-Sliwa A, Dambska M.

Folia Neuropathol. 1998;36(2):81-6.

PMID:
9757618
10.

Expression of bcl-2 is associated with microvessel density in olfactory neuroblastoma.

Diensthuber M, Potinius M, Rodt T, Stan AC, Welkoborsky HJ, Samii M, Schreyögg J, Lenarz T, Stöver T.

J Neurooncol. 2008 Sep;89(2):131-9. doi: 10.1007/s11060-008-9602-9. Epub 2008 Apr 23.

PMID:
18431543
11.

Comprehensive Molecular Profiling of Olfactory Neuroblastoma Identifies Potentially Targetable FGFR3 Amplifications.

Lazo de la Vega L, McHugh JB, Cani AK, Kunder K, Walocko FM, Liu CJ, Hovelson DH, Robinson D, Chinnaiyan AM, Tomlins SA, Harms PW.

Mol Cancer Res. 2017 Nov;15(11):1551-1557. doi: 10.1158/1541-7786.MCR-17-0135. Epub 2017 Aug 3.

PMID:
28775129
12.

[Olfactory neuroblastoma with unusual structures: a clinical pathologic study].

Yao Q, Yue CL, Lü ZC, Han YD, Liu HG.

Zhonghua Bing Li Xue Za Zhi. 2009 Mar;38(3):163-8. Chinese.

PMID:
19575850
13.

Cytopathologic features of olfactory neuroblastoma.

Mahooti S, Wakely PE Jr.

Cancer. 2006 Apr 25;108(2):86-92.

14.

Olfactory neuroblastoma in dogs and cats--a histological and immunohistochemical analysis.

Brosinski K, Janik D, Polkinghorne A, Von Bomhard W, Schmahl W.

J Comp Pathol. 2012 Feb-Apr;146(2-3):152-9. doi: 10.1016/j.jcpa.2011.06.002. Epub 2011 Jul 23.

PMID:
21783199
15.

Activation of sonic hedgehog signaling pathway in olfactory neuroblastoma.

Mao L, Xia YP, Zhou YN, Dai RL, Yang X, Wang YJ, Duan SJ, Qiao X, Mei YW, Hu B.

Oncology. 2009;77(3-4):231-43. doi: 10.1159/000236047. Epub 2009 Sep 7.

PMID:
19738389
16.

Comprehensive molecular profiling of advanced/metastatic olfactory neuroblastomas.

Topcagic J, Feldman R, Ghazalpour A, Swensen J, Gatalica Z, Vranic S.

PLoS One. 2018 Jan 11;13(1):e0191244. doi: 10.1371/journal.pone.0191244. eCollection 2018.

17.

Neuroendocrine Neoplasms of the Sinonasal Tract: Neuroendocrine Carcinomas and Olfactory Neuroblastoma.

Shah K, Perez-Ordóñez B.

Head Neck Pathol. 2016 Mar;10(1):85-94. doi: 10.1007/s12105-016-0696-7. Epub 2016 Feb 1. Review.

18.

[Expression of SSTR2 and P-STAT3 in human olfactory neuroblastoma].

Zeng M, Cui Y, Wu C.

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2010 Aug;24(15):690-2. Chinese.

PMID:
20942237
19.

Comparative immunohistochemical analysis of pulmonary and thymic neuroendocrine carcinomas using PAX8 and TTF-1.

Weissferdt A, Tang X, Wistuba II, Moran CA.

Mod Pathol. 2013 Dec;26(12):1554-60. doi: 10.1038/modpathol.2013.111. Epub 2013 Jun 21.

20.

Clincopathological analysis of olfactory neuroblastoma.

Fukushima S, Sugita Y, Niino D, Mihashi H, Ohshima K.

Brain Tumor Pathol. 2012 Oct;29(4):207-15. doi: 10.1007/s10014-012-0083-3. Epub 2012 Feb 14.

PMID:
22331316

Supplemental Content

Support Center